These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1359630

  • 1. Clinical evaluation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2.
    Kawa S, Kato M, Oguchi H, Hsue GL, Kobayashi T, Koiwai T, Tokoo M, Furuta S, Ichikawa T, Kanai M.
    Scand J Gastroenterol; 1992 Aug; 27(8):635-43. PubMed ID: 1359630
    [Abstract] [Full Text] [Related]

  • 2. Preparation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2.
    Kawa S, Kato M, Oguchi H, Kobayashi T, Furuta S, Kanai M.
    Scand J Gastroenterol; 1991 Sep; 26(9):981-92. PubMed ID: 1682994
    [Abstract] [Full Text] [Related]

  • 3. Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype.
    Kawa S, Oguchi H, Kobayashi T, Tokoo M, Furuta S, Kanai M, Homma T.
    Br J Cancer; 1991 Nov; 64(5):899-902. PubMed ID: 1931612
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epitope analysis of SPan-1 and DUPAN-2 using synthesized glycoconjugates sialyllact-N-fucopentaose II and sialyllact-N-tetraose.
    Kawa S, Tokoo M, Oguchi H, Furuta S, Homma T, Hasegawa Y, Ogata H, Sakata K.
    Pancreas; 1994 Nov; 9(6):692-7. PubMed ID: 7531332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of glycoconjugates in pancreatic, gastric, and colonic tissue by Bauhinia purpurea, Vicia villosa, and peanut lectins.
    Shue GL, Kawa S, Kato M, Oguchi H, Kobayashi T, Koiwai T, Tokoo M, Furuta S, Kanai M, Homma T.
    Scand J Gastroenterol; 1993 Jul; 28(7):599-604. PubMed ID: 8362212
    [Abstract] [Full Text] [Related]

  • 10. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ, Bi N, Yan PS, Yuan M, Norton KA, Kim YS.
    Cancer Res; 1991 Jan 01; 51(1):372-80. PubMed ID: 1703039
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical usefulness of tumor markers associated with pancreatic cancer].
    Watanabe H, Kawakami H, Yamakawa O, Satomura Y, Ohta H, Motoo Y, Okai T, Sawabu N.
    Rinsho Byori; 1994 Feb 01; 42(2):127-38. PubMed ID: 7908065
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.